NVAX US Equity
Novavax IncHealth Care · Biological Products, (No Diagnostic Substances) · CIK 1000694 · FY ends Dec 31$8.79
+0.86 (+10.84%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 45.7M |
| % of shares out | 27.7% |
| Days to cover | 16.6 |
| Δ vs 2026-07-15 | +4.2% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 45,659,491 | +4.2% | 2,746,393 | 16.6 |
| 2026-07-15 | 43,821,227 | -4.3% | 3,835,115 | 11.4 |
| 2026-06-30 | 45,809,886 | +1.5% | 4,935,619 | 9.3 |
| 2026-06-15 | 45,113,281 | -1.9% | 4,181,161 | 10.8 |
| 2026-05-29 | 45,965,363 | +1.5% | 5,866,242 | 7.8 |
| 2026-05-15 | 45,278,456 | -8.5% | 7,134,181 | 6.3 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
